Results of the Destination Therapy Post-Food and Drug Administration Approval Study With a Continuous Flow Left Ventricular Assist Device
Ulrich P. Jorde(Montefiore Health System), Soon J. Park(Mayo Clinic), Emma J. Birks(Lung Institute), Douglas Horstmanshof(INTEGRIS Baptist Medical Center), David J. Farrar(Southwestern Medical Center), Sudhir S. Kushwaha(Mayo Clinic in Arizona), James W. Long(Pennsylvania State University), Robert L. Kormos(Abbott Northwestern Hospital), Antone Tatooles(Rush University Medical Center), Jeffrey J. Teuteberg(Stanford University), Yoshifumi Naka(Cornell University), Geetha Bhat(Christ Hospital), Mark S. Slaughter(University of Louisville)
Cited by 243
Related Papers
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711
Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation
|Circulation|2012|655
Continuous Flow Left Ventricular Assist Device Improves Functional Capacity and Quality of Life of Advanced Heart Failure Patients
|Journal of the American College of Cardiology|2010|583